Bauer E. Sumpio
Yale University
383 Papers
4.3K Citations
Bauer E. Sumpio is an academic researcher from Yale University. The author has contributed to research in topics: Medicine & Endothelial stem cell. The author has an hindex of 68, co-authored 375 publications. Previous affiliations of Bauer E. Sumpio include University of North Carolina at Chapel Hill & Utrecht University.
Chat about Author
Papers
Application of Porter’s Five Forces Model and generic strategies for vascular surgery: should be stuck in the middle?
TL;DR: By understanding the nature of the Porter's Five Forces as it applies to vascular surgery, and by appreciating their relative importance, the authors' society would be in a stronger position to defend itself against threats and perhaps influence the forces with a long-term strategy.
9
Omental Vein Catheter Thrombolysis for Acute Porto-Mesenteric Vein Thrombosis
TL;DR: A patient who presented with acute-onset MVT and bowel infarction was successfully ameliorated with intramesenteric vein thrombolytic therapy.
9
Traumatic innominate artery pseudoaneurysm in the setting of a bovine arch.
Alfredo C. Cordova,Alfredo C. Cordova,Frank Bowen,Frank Bowen,Leigh Ann Price,Stanley J. Dudrick,Bauer E. Sumpio +6 more
TL;DR: A case of traumatic innominate artery pseudoaneurysm in the setting of "bovine aortic arch" anatomy, together with multiple associated injuries, including descending aorta transection is reported.
9
Venous Ulcer: Late Complication of a Traumatic Arteriovenous Fistula
Calvin Young,Alan Dardik,Bauer E. Sumpio,Jeff E. Indes,Bart E. Muhs,Cassius Iyad Ochoa Chaar +5 more
TL;DR: A traumatic femoral AVF causing distal venous ulceration 3 years after the injury is described, which has not recurred at 1-year follow-up.
9
The influence of perfusate viscosity, RBC deformability and drag on the function of an isolated perfused rat kidney.
TL;DR: It is concluded that rheologic manipulation of a perfusate solution can alter flow and renal function and adding a drag-reducing agent improves renal function at 20% hematocrit.
9